What It Does: Cellworks provides you with an opportunity to engage with the leading world experts in human biology and medicine.
Mission: To serve patients through advances in personalized medicine that significantly improve treatment success.
Size & Presence: 116 employees located in Bangalore India.
Founded in 2005 and backed by UnitedHealth Group, Sequoia Capital, Agilent and Artiman, Cellworks has built the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modellers and software technologists working towards a common goal of fighting disease to improve the lives of patients. Cellworks’ areas of therapeutic focus are oncology and immunology.
In the clinical setting, our products provide physicians with a TRI report that informs therapy choices. We change the economics of drug development and targeting by assisting BioPharma in accomplishing higher clinical trial success rates and resurrecting failed drugs. We drive down costs across the healthcare system by cutting out the trial and error of therapy selection and providing payors with transparency into the causative rationale of therapeutic recommendations. Critically, through early identification of the best therapy, we improve patient outcomes and save them from debilitating and costly rounds of unsuccessful treatment.
Cellworks’ personalized medicine products use AI-enhanced biosimulation to make phenotype predictions, which are then clinically validated. Our technology foundation is the Cellworks platform, which was conceived as a unified representation of biological knowledge collected from all known heterogeneous datasets. Our groundbreaking and unconventional technology applies advanced modelling and quantitative prediction techniques that mirror the methodology used to design and validate semiconductor chips to simulate a patient’s response to FDA approved drugs, replacing trial and error in matching patients and therapies.
Cellworks is a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology. Using innovative multi-omics modelling, computational biosimulation and Artificial Intelligence heuristics, Cellworks predicts the most efficacious therapies for patients. The Cellworks unique biosimulation platform is a unified representation of biological knowledge curated from heterogeneous datasets and applied to finding cures. Backed by UnitedHealth Group, Sequoia Capital, Agilent and Artiman, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modellers and software technologists working toward a common goal – attacking serious diseases to improve the lives of patients
Our culture puts patients at the centre of all our activities, driving innovation, motivating each of us to excel and deliver the most compelling therapies for the most confounding diseases.
Engage in exciting new drug therapy research and drug discovery. Start your adventure in advancing rational treatment decisions for human disease. Cellworks provides you with an opportunity to engage with the leading world experts in human biology and medicine. The group has spent over a thousand man-years curating and holistically modelling human biology, for the purpose of improving the treatment of patients with serious illnesses. We impact human disease and make a difference in patients’ lives.
Cellworks is headquartered in the heart of Silicon Valley, with R&D offices in dynamic Bangalore, India. We offer an entrepreneurial collaborative start-up environment with the brightest in the field, dynamic fast-paced professional growth, and fun team-building activities with the unified goal of changing the landscape of therapeutics.
Precision medicine is the new wave of genome-based treatment decisions and drug development. Join us as we make innovative advances with a new paradigm for bio-simulation based therapies to help millions of patients worldwide.